Binocular Video Game Doesn't Up Visual Function in Amblyopia

Share this content:
Binocular Video Game Doesn't Up Visual Function in Amblyopia
Binocular Video Game Doesn't Up Visual Function in Amblyopia

TUESDAY, Jan. 9, 2018 (HealthDay News) -- A home-based binocular falling-blocks video game does not improve visual outcomes more than placebo for children and adults with unilateral amblyopia, according to a study published online Jan. 4 in JAMA Ophthalmology.

Tina Y. Gao, from the University of Auckland in New Zealand, and colleagues compared the effectiveness of a binocular video game with a placebo video game for improving visual functions. A total of 115 participants aged 7 years and older with unilateral amblyopia were recruited and allocated to receive the active or placebo video game.

The researchers found that the mean amblyopic eye visual acuity improved from baseline by 0.06 and 0.07 logMAR in the active and placebo groups, respectively. After adjustment for baseline visual acuity and age group, the mean treatment difference between the groups was −0.02 logMAR (95 percent confidence interval, −0.06 to 0.02; P = 0.25). Sixty-four percent of participants in the active group and 83 percent in the placebo group achieved compliance with more than 25 percent of prescribed game play. Sixty-four percent of the active group achieved fellow eye contrast greater than 0.9 at six weeks. There were no differences between the groups for any secondary outcomes.

"More engaging video games with considerations for compliance may improve effectiveness," the authors write.

Two authors are named inventors on two patents that cover the binocular video game treatment used in the clinical trial.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »